Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 22 , ISSUE 2 ( July-December, 2020 ) > List of Articles

Original Article

The impact of different methods of COVID-19 sample analysis upon patient stay duration between arrival at the emergency department and hospital admission

Talhah Mohammed, Mitul Patel

Keywords : Emergency department, SARS-CoV2, turnaround times

Citation Information : Mohammed T, Patel M. The impact of different methods of COVID-19 sample analysis upon patient stay duration between arrival at the emergency department and hospital admission. 2020; 22 (2):82-84.

DOI: 10.4103/jacm.jacm_32_21

License: CC BY-NC 4.0

Published Online: 05-04-2021

Copyright Statement:  Copyright © 2020; Wolters Kluwer India Pvt. Ltd.


Abstract

BACKGROUND: Sars-Cov2 is a respiratory disease causing virus that originated in Wuhan, China with the officials in the country first reporting it in December 2019. It results in the condition Covid-19, with the main symptoms associated with the virus being a high temperature, a continuous cough and a loss or change of taste and smell. AIMS AND OBJECTIVES: An assessment of service provision was conducted to see how the involvement of different analysers with its different systems, impacted upon the duration that patients spent on Paediatric Assessment Unit (PAU); an intermediary unit linking the Emergency Department to further hospital wards. The preferred screening for the virus by Public Health England (PHE) involves molecular diagnosis by real-time PCR. MATERIALS AND METHODS: Fifty samples were collected between March and July, and the patient duration spent on PAU was seen to decrease as the months progressed. To the best of our knowledge, this is a novel study which has not yet taken place before. RESULTS: As the months progressed, the average time patients spent on PAU from March to July was shown to have reduced. CONCLUSION: The decrease in duration mirrored the change in service provision; namely the implementation of a random-access analyser, allowing for enhanced patient movement within the hospital.


PDF Share
  1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 94. Geneva: World Health Organization; 2020.
  2. Coronavirus.data.gov.uk. Coronavirus (COVID-19) in the UK; 2020. Available from: https://coronavirus.data.gov.uk/. [Last accessed on 2020 Aug 11].
  3. Wise J. COVID-19: What's going wrong with testing in the UK? BMJ 2020;370:3678. Available from: https://www.bmj.com/content/370/bmj.m3678. [Last accessed on 2020 Oct 02].
  4. Aptima® SARS-CoV-2 Product Literature Assay (Panther System). Geneva: Hologic; 2020. p. 3.
  5. Brendish NJ, Poole S, Naidu VV, Mansbridge CT, Norton NJ, Wheeler H, et al. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): A prospective, interventional, non-randomised, controlled study. Lancet Respir Med 2020;8:1192-1200.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.